Market
CereVasc raises $85m to advance hydrocephalus treatment
CereVasc raised $85 million to advance development of eShunt, an implantable system for treating normal pressure hydrocephalus through cerebrospinal fluid drainage. The funding supports clinical advancement and commercialization of the device.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network